Navigation Links
Celsis Launches RapiScreen(TM) Beverage Microbial Screening System

CHICAGO, Nov. 20 /PRNewswire/ -- Celsis International plc (LSE: CEL.L), the global leader in rapid microbial detection solutions for industry, today announced the launch of RapiScreen(TM) Beverage, a new assay for use on the Celsis Innovate -- the company's proven rapid microbial screening instrument for dairy products. This new rapid screening test kit extends the Celsis Innovate platform to efficiently and rapidly screen Ultra Heat Treated (UHT) and Extended Shelf Life (ESL) beverage products for microbial contamination.

The flexibility and high-throughput of the Celsis Innovate system makes it ideal for companies that produce beverage and dairy products alike. The RapiScreen Beverage kit works on everything from clear to pulpy juices, from broths to soups, with no filtering necessary.

"Many of our dairy industry customers are expanding their product portfolios to include non-dairy products such as nutritional shakes and fruit- or broth-based items," said Judy Madden, VP of the Celsis Rapid Detection division. "With the addition of the RapiScreen Beverage kit for the Innovate, the same trusted platform now can be used to test for contamination across their entire spectrum of products, quickly and efficiently."

Adenosine Triphosphate (ATP) bioluminescence is the industry standard for the rapid microbial screening of UHT and ESL beverage products. Using proprietary innovations in enzyme technology, RapiScreen Beverage for Innovate delivers reliable and consistent results on a broad range of products in 24-48 hours. Additional benefits include:

    --  Validation available on a wide variety of UHT/ESL beverage products
        including broths, soups, sport drinks, ready-to-drink teas,
        yogurt-based drinks, fruit juices and nutritional supplements
    --  Effective on low pH products
    --  Equally effective with filterable and non-filterable products
    --  Process is non-destructive, allowing for further testing if needed
    --  Validated on a wide range of microorganisms

The Celsis RapiScreen Beverage kit offers a cost-effective, rapid screening solution for the Innovate platform that drives quick results and ROI. Companies interested in learning more about RapiScreen Beverage for the Innovate can visit for more information.

About Celsis Rapid Detection Systems

By significantly reducing the time required to test and release raw materials, in-process and finished goods, manufacturers using Celsis Rapid Detection systems realize improved cash flow and reduced working-capital requirements, while ensuring quality and increased responsiveness throughout the supply chain. Celsis' extensive client base includes many of the world's leading pharmaceutical and consumer products companies. Founded in the UK and now headquartered in Chicago, the Company has been listed on the London Stock Exchange (CEL.L) since 1993.

SOURCE Celsis International plc
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Celsis Receives Frost & Sullivan 2008 Best Practices Award
2. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
3. Novozymes Launches Enzyme to Reduce Acrylamide in Food
4. Enova Medical Launches Exos Corporation
5. Elekta Launches New Linear Accelerator at 2007 ESTRO to Expand Cancer Treatment Availability
6. Signalifes Dr. Harmison Launches Award-Winning Ambulatory Heart Monitor
7. ThirdBiotech Networking Group Launches
8. BioReliance Launches Next-Generation Genotoxicity Screening Service
9. Midwest Research Institute Launches Center for Biological Safety and Security (CBS2)
10. BioReliance Corporation Launches iNet(TM) for Online Results Tracking of Biological Safety Tests
11. Kingfisher Healthcare Launches Breakthrough Product in Europe
Post Your Comments:
(Date:11/24/2015)... /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: AEZ) (the ... the Toronto Stock Exchange, confirms that as of the ... developments that would cause the recent movements in the ... --> About Aeterna Zentaris Inc. ... Aeterna Zentaris is a specialty biopharmaceutical company engaged in ...
(Date:11/24/2015)... LEXINGTON, Massachusetts , November 24, 2015 ... Officer, will participate in the Piper Jaffray 27 th Annual ... on Tuesday, December 1, 2015, at 8:30 a.m. EST (1:30 p.m. ... Poulton , Chief Financial Officer, will participate in the Piper Jaffray ... City , NY on Tuesday, December 1, 2015, at 8:30 ...
(Date:11/24/2015)... , ... November 24, 2015 , ... ... the environment are paramount. Insertion points for in-line sensors can represent a weak ... the InTrac 781/784 series of retractable sensor housings , which are designed ...
(Date:11/24/2015)... 24, 2015 HemoShear Therapeutics, LLC, a ... for metabolic disorders, announced today the appointment of ... of Directors (BOD). Mr. Watkins is the former ... Sciences (HGS), and also served as the chairman ... Powers , Chairman and CEO of HemoShear Therapeutics. ...
Breaking Biology Technology:
(Date:11/19/2015)... -- Although some 350 companies are actively involved in molecular ... according to Kalorama Information. These include Roche Diagnostics, Hologic, Abbott ... of the 6.1 billion-dollar molecular testing market, according to ... Diagnostic s .    ... one company and only a handful of companies can ...
(Date:11/18/2015)... --> --> ... report titled  Gesture Recognition Market - Global Industry Analysis, ... to the report, the global gesture recognition market was valued at ... US$29.1 bn by 2021, at a CAGR of 20.3% ... dominated the global gesture recognition market in ...
(Date:11/17/2015)... 17, 2015 Paris ... --> Paris , qui s,est ... DERMALOG, le leader de l,innovation biométrique, a inventé le ... et empreintes sur la même surface de balayage. Jusqu,ici, ... l,autre pour les empreintes digitales. Désormais, un seul scanner ...
Breaking Biology News(10 mins):